Azitra, Inc.

Name: Azitra, Inc. standardized financial statements, quarterly
Creator: Listed

AZTRNYSECIK 1701478HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025

Operating income−$3.4m, Q2 FY2026

Net income−$3.3m, Q2 FY2026

Azitra, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	311	90.0	0.0	7.5	0.0	0.0	not reported	0.0	0.0	0.0	not reported	not reported
Research and development	$k	549	1,511	1,473	1,119	1,016	1,116	1,250	1,402	1,180	1,004	1,561	1,352
Operating income	$k	(1,994)	(2,470)	(2,961)	(2,660)	(2,929)	(2,434)	(3,100)	(2,871)	(2,768)	(2,227)	(3,934)	(3,419)
Interest expense	$k	0.7	1.0	0.9	1.8	3.9	5.6	1.3	0.5	0.4	5.5	3.4	1.4
Income tax	$k	0.0	7.6	0.0	0.0	0.0	9.0	0.0	0.0	0.0	8.3	0.0	0.0
Net income	$k	(1,943)	(2,454)	(2,933)	(2,632)	(1,009)	(2,393)	(3,068)	(2,889)	(2,765)	(2,234)	(3,927)	(3,348)
Diluted EPS	$ per share	(4.82)	not reported	(4.32)	(2.74)	(1.14)	not reported	(1.55)	(1.18)	(0.67)	not reported	(0.25)	(0.17)
Basic EPS	$ per share	(4.82)	not reported	(4.32)	(2.74)	(1.14)	not reported	(1.55)	(1.18)	(0.67)	not reported	(0.25)	(0.17)

Balance sheet

Cash and equivalents$6.7m, Q2 FY2026

Shareholders' equity$7.3m, Q2 FY2026

Azitra, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	4.4	1.8	3.0	0.8	7.3	4.6	3.2	1.0	1.4	2.1	10.1	6.7
Current assets	$m	4.9	2.5	3.5	1.3	7.6	5.2	3.9	1.8	2.2	3.0	10.8	7.4
Total assets	$m	7.5	5.1	6.1	3.9	9.8	7.4	5.9	4.0	4.3	5.0	12.1	8.9
Current liabilities	$m	1.5	1.6	1.3	1.7	1.4	1.4	1.3	1.5	1.8	1.1	1.5	1.5
Total liabilities	$m	2.2	2.2	1.7	2.2	1.7	1.7	1.5	1.7	2.0	1.2	1.6	1.6
Shareholders' equity	$m	5.3	2.9	4.3	1.7	8.1	5.7	4.4	2.2	2.3	3.8	10.5	7.3

Cash flow

Operating cash flow−$3.3m, Q2 FY2026

Capital expenditure$40.1k, Q2 FY2026

Azitra, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,792)	(2,539)	(3,020)	(2,102)	(2,476)	(2,586)	(3,072)	(2,815)	(2,445)	(2,893)	(2,477)	(3,291)
Capital expenditure	$k	5.3	3.7	0.0	0.0	8.6	0.0	0.0	11.6	3.4	9.2	14.9	40.1

Diluted shares (weighted)19.30m, Q2 FY2026

Azitra, Inc., shares, quarterly
Line item	Unit	period not labelled2022-09-30	period not labelled2023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	1.1	1.1	0.1	0.4	0.7	1.0	0.9	2.0	2.4	4.1	15.5	19.3

Shares outstanding: 60.60m at Aug 11, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.